DNA CapEx to Revenue
Ginkgo Bioworks Holdings Inc Class · CapEx to Revenue
DNA CapEx to Revenue
Current (TTM)17.77%retrieved
DNA CapEx/Revenue (41.01% → 17.77%)
Latest values, visible window
High-resolution chart · PNG
DNA capex to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 4.5047% | |
| 27.5459% | |
| 16.226% | |
| 10.9421% | |
| 18.0097% | |
| 75.4282% | |
| 41.0066% |